5 Aug 2022 , 08:22 AM
Net profit of Glenmark Life Sciences rose 7.75% to Rs 108.73 crore in the quarter ended June 2022 as against Rs 100.91 crore during the previous quarter ended June 2021. Sales declined 6.67% to Rs 489.87 crore in the quarter ended June 2022 as against Rs 524.90 crore during the previous quarter ended June 2021.
| Particulars | Quarter Ended | ||
| ? | Jun. 2022 | Jun. 2021 | % Var. |
| Sales | 489.87 | 524.90 | -7 |
| OPM % | 29.96 | 30.57 | – |
| PBDT | 156.13 | 143.88 | 9 |
| PBT | 146.25 | 134.96 | 8 |
| NP | 108.73 | 100.91 | 8 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
